Justin Martello is a Neurology physician. OpenAlex indexes 18 publications with 772 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Hygeia Dr Ste 1420
Newark, DE 197132049
Telephone
302-623-3017Provider last certified this registry record 31 Jan 2023.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ACADIA Pharmaceuticals IncProgram year202563 payments$57,217openpaymentsdata.cms.gov ↗
- Teva Pharmaceuticals USA, Inc.Program year202528 payments$45,631openpaymentsdata.cms.gov ↗
- Neurocrine BioSciences, Inc.Program year202531 payments$28,872openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
58.2%Neuromuscular Blocker57.3%Onabotulinumtoxina100%Part B, office-administered≥15 patientsgamma-Aminobutyric Acid-ergic Agonist0.6%Baclofen100%Part D<11 patients+ 1 more class in this area
Nervous system
37.7%Aromatic Amino Acid Decarboxylation Inhibitor12.3%Carbidopa-Levodopa70%Rytary21%Carbidopa-Levodopa Er6%Crexont3%Part D≥264 patientsBenzodiazepine3.4%Clonazepam88%Alprazolam7%Diazepam5%Part D<11 patients+ 21 more classes in this area
Cardiovascular
3.6%Beta blocker2.5%Propranolol Hcl63%Propranolol Hcl Er37%Part D≥43 patientsAdrenergic and dopaminergic agents0.6%Droxidopa100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- An Introduction to Quantitative Aspects of Quality Improvement Science
Neurology Clinical Practice
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”